01.12.2011 | Controversy | Ausgabe 4/2011
Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?
- Zeitschrift:
- memo - Magazine of European Medical Oncology > Ausgabe 4/2011